VVOS · Vivos Therapeutics, Inc. · Documents
$0.15
+0.00 (+1.52%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, we had approximately $1.8 million in cash and cash equivalents, which will not be sufficient to fund operations and strategic objectives over the next twelve months from the date of the issuance of these financial statements. Without additional financing, these factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.83M
Shares
20.12M
Volume · Oct 5
585.84K
Avg daily vol (3M)
12.34M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-10-01 | 2026-09-29 | |
| 8-K | 2026-09-08 | 2026-08-31 | |
| 8-K/A | 2026-09-08 | 2026-09-02 | |
| 8-K | 2026-08-21 | 2026-08-20 | |
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-08-11 | 2026-08-05 | |
| 8-K | 2026-08-03 | 2026-07-31 | |
| 8-K | 2026-07-07 | — | |
| 8-K | 2026-06-25 | — | |
| 8-K | 2026-06-16 | 2026-06-15 | |
| 8-K | 2026-06-16 | — | |
| 8-K | 2026-06-08 | — | |
| 10-Q | 2026-05-20 | 2026-03-31 | |
| 8-K | 2026-04-22 | — | |
| 8-K | 2026-04-15 | — | |
| 10-K | 2026-04-15 | 2025-12-31 | |
| 8-K | 2026-04-03 | — | |
| 8-K | 2026-02-06 | — | |
| 8-K | 2026-01-20 | — | |
| 8-K | 2026-01-16 | — | |
| 8-K | 2025-12-17 | 2025-12-16 | |
| 8-K | 2025-12-05 | — | |
| 10-Q | 2025-11-19 | 2025-09-30 | |
| 8-K | 2025-11-19 | — | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-10-24 | — | |
| DEF 14A | 2025-09-29 | 2025-09-26 | |
| 8-K | 2025-09-18 | 2025-09-17 | |
| 8-K | 2025-09-12 | — | |
| 8-K/A | 2025-08-25 | 2025-06-09 | |
| 8-K | 2025-08-20 | — | |
| 10-Q | 2025-08-19 | 2025-06-30 | |
| 8-K | 2025-06-13 | — | |
| 8-K | 2025-06-06 | — | |
| 8-K | 2025-05-23 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-15 | — | |
| 8-K | 2025-04-17 | — | |
| 8-K | 2025-03-31 | — | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-02-14 | — | |
| 8-K | 2024-12-23 | — | |
| 8-K | 2024-11-27 | — | |
| 8-K | 2024-11-14 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| DEF 14A | 2024-10-07 | — | |
| 8-K | 2024-09-20 | — | |
| 8-K | 2024-09-18 | — | |
| 8-K | 2024-09-17 | — | |
| 8-K | 2024-09-12 | — |
Showing 1–50 of 114 filings